Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133627) titled 'Toward AI-Powered Precision Diagnosis and Subtyping of Migraine via Multicenter Super-Resolution MRI Fusion' on Sept. 29.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The First Medical Centre, Chinese PLA General Hospital
Condition:
migraine
Intervention:
Migraine group:none
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-08
Target Sample Size: Migraine group:500;Healthy control group:500;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=343384
Published by HT Digital Content Services with...